Wedbush Boosts Lexicon Pharmaceuticals, Inc. (LXRX) Price Target to $38.00
The brokerage currently has an outperform rating on the biopharmaceutical company's stock. A number of other research firms also recently weighed in on LXRX.
from Biotech News
0 Comments